Skip to main content

Bristol Myers Squibb to Participate in the 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference in New York City on Thursday, January 4, 2024. Adam Lenkowsky, executive vice president, chief commercialization officer, will answer questions about the company during a fireside chat at 11 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session here. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.47
+2.52 (1.16%)
AAPL  259.82
+1.37 (0.53%)
AMD  235.31
+5.08 (2.21%)
BAC  51.73
+0.63 (1.24%)
GOOG  255.23
+2.70 (1.07%)
META  733.75
+0.34 (0.05%)
MSFT  523.29
+2.75 (0.53%)
NVDA  182.72
+2.44 (1.36%)
ORCL  282.67
+10.01 (3.67%)
TSLA  445.44
+6.47 (1.47%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.